TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Binge Eating Scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in Compass-31 survey
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change from baseline in Pittsburg Sleep Quality Index (PSQI)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change from baseline in Insomnia Severity Scale Index (ISI)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Papilledema
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of Participants Recruited Within the Goal of 12 Months
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Zarit Burden Inventory Score
Endpoint domain: Life impact
Endpoint subdomain: Societal/carer burden
Primary endpoint: Perceived Stress Scale Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Blood biochemistry findings in newborns
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HCV cure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Critical variable completeness
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of PROs collected per patient
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of specimens per participant collected
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Occurrence of a Grade 2 or higher Adverse Radiation Effect
Endpoint domain: Adverse events/effects
Primary endpoint: Ocular manifestations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Systemic manifestations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Urinary Tract Infection (UTI)
Endpoint domain: Adverse events/effects
Primary endpoint: Sleep disorder severity
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Percentage of patients developing grade 3 CNS toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: turnaround time for eXDR positive detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ISTH major bleeding occurring during OAC + clopidogrel intake
Endpoint domain: Adverse events/effects
Primary endpoint: Proportions of undetectable HBV DNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Quality of Life of patients
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Missed diagnosis rate of adenoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Carotid plaque progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in the levels of pain during the first month of treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the levels of pain during the third month of treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the levels of discomfort during the first month of treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the levels of discomfort during the third month of treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the levels of swelling during the first month of treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of MTR™
Endpoint domain: Adverse events/effects
Primary endpoint: Effectiveness of MTR™
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Molecular modifications
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MADRS Change from Baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total morphine T24
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Iowa Gambling Task (IGT) net scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Difference in estimated Hba1c
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Maximum Observed Plasma Concentration (Cmax) of MDZ
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration Versus Time Curve (AUC) of MDZ
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postoperative analgesic effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pain outcomes
Primary endpoint: Percentage of family participation
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Rhythmicity of melatonin concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Medication compliance rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Spinal anesthesia induced hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in left atrial volume index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Prevalence of Babesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Prevalence of local recurrence of breast cancer
Endpoint domain: Mortality/survival
Primary endpoint: Change in pain levels as measured by the BPI-T
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Total dosage of analgesic drug
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Level of salivary alpha-amylase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life post mastectomy
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Vulvar blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: 2 minute stair test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Steady state concentrations of tenofovir disphosphate (TFV-DP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knee MRI measurements of fat pad thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knee MRI measurements of fat pad surface area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knee MRI measurements of fat pad volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants with Cerebral Hyperperfusion Syndrome
Endpoint domain: Adverse events/effects
Primary endpoint: Redness, Edema, Ecchymosis, Discharge, and Approximation score (REEDA score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified Severity Score (MSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes of clinical characteristic
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: social psychology
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Knee Injury and Osteoarthritis Outcome Score (KOOS) or Hip Injury and Osteoarthritis Outcome Score (HOOS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in Pain Catastrophizing scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Box and Block Test score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Improvement in hyperhidrosis severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life (QoL) assessment
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Progression free survival rate at 12 months
Endpoint domain: Mortality/survival
Primary endpoint: ADHD medication initiation immediately after intervention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percent of days covered with ADHD medication immediately after intervention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Satisfaction with Intervention Immediately after Intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: incidence of successful management of severe post-spinal hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Circulating intercellular adhesion molecule 1 (ICAM-1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Circulating Vascular adhesion molecule 1 (VCAM-1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Opioid consumption decrease
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in Decision-Making Styles Scale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Decrease in mean score of the Problem Solving Inventory
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Timed Up & Go
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Infusion Related Reactions (IRRs)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Injection site reactions (ISRs)
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in the Montreal Cognitive Assessment score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Erythema time courses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: FVIII/FIX Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: FVIII/FIX inhibitor concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Holmes-Rahe Life Stress Inventory
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: The Brief Resilience Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: The Work and Well-being Survey (UWES)© Engagement Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Advanced Practice Provider Well-being Index
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Time to development of G2 RID
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma appearance of dietary amino acids
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of grade 3-5 treatment-related AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Dentition status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: International Incontinence Consultation Questionnaire-Short Form
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Urogenital Distress Inventory (UDE-6)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in pre vs. post test scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change From Baseline in the Amount of SARS-CoV-2 Virus RNA for AT-527 550 mg
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change From Baseline in the Amount of SARS-CoV-2 Virus RNA for AT-527 1100 mg
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: MPS equivalency with and without DRE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MPS validity rate with and without DRE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Revised Oswestry Disability Index (RODQ)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Prone Double Straight-Leg Raise Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of gastrointestinal symptoms control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Accuracy of microvessel ultrasound imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fasting plasma glucose in mg/dl
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Alanine aminotransferase (liver enzyme) in U/L
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distance-corrected intermediate ETDRS LogMar visual acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Best corrected distance ETDRS LogMar visual acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of HIV tests performed with result returned
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Improvement of upper limb mobility
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: postoperative hearing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Force of pressing grip force device (GFD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reward-related brain responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reward anticipation on a neural level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of new clinically significant PE
Endpoint domain: Mortality/survival
Primary endpoint: incidence of absorbable filter deployment without complications
Endpoint domain: Adverse events/effects
Primary endpoint: incidence of all DVT post index event
Endpoint domain: Adverse events/effects
Primary endpoint: composite rate of technical filter placement success without complications
Endpoint domain: Adverse events/effects
Primary endpoint: Victorian Institute of Sport Assessment-Proximal Hamstring Tendons (VISA-H) questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Isometric and eccentric muscle force
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in propeptide of type 1 procollagen (P1NP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of attempts to successful cannulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Depressive symptoms evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinical cure rate of bacterial vaginosis symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: microbiological cure rate of bacterial vaginosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: recurrence rate of bacterial vaginosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severe adverse device events (SADEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of recruited patients
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Time-weighted average changes in SARSCoV-2 RNA levels in nasopharyngeal swabs from baseline to Day 8
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radiological parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Voice-Handicap Index (VHI-30)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change From Baseline in Forced Vital Capacity (FVC) (mL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Accommodation gastric volumes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Cumulative Procedure Time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Point prevalence, period prevalence and incidence of common mental disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maturation of Arteriovenous Fistula (AVF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Complete anaesthesia of the airway
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Position of NAVA catheter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: success of a full curative therapeutic
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants who meet criteria for hypertension based on average home BP reading
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of participants who meet criteria for hypertension based on 24-hour ambulatory BP reading
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percent agreement between home BP-reading based diagnosis versus 24-hour ABPM
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time to potency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CDKL5 Deficiency Disorder (CDD) Clinical Severity Assessment - Clinician
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of Life Inventory - Disability
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: CDKL5 Deficiency Disorder (CDD) Gross Motor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ACPA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Duration-based device expulsion parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pressure-based device expulsion parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: WHO/ISUP grade
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Bath Ankylosing Spondylitis Disease Activation Index (BASDAI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Oxygen use (VO2max)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of us-qFIT to diagnose colorectal advanced adenoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Height gained
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Width gained
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Outcome of adult LCH patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of electrographic epileptiform activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Prevalence of ED
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mother's postpartum parenting behavior mean scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mother's breastfeeding self-efficacy scale mean scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mother's readiness for hospital discharge scale mean scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Positive Airway Pressure (PAP) minutes per night
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nights of PAP use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PROMIS Pain Interference change
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: progression of CKD (eGFR <90 mL/min/1·73 m2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: rapid eGFR decline (eGFR loss >3·0 mL/min/1·73 m2 per year)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Mean change in whole-body skeletal muscle mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants with PASI 90 Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Oxford Hip score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Safety and tolerability of KIO-301
Endpoint domain: Adverse events/effects
Primary endpoint: Scores of gastrointestinal symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Total sodium loss (in mmol of sodium) per 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Occurrence of composite endpoint (acute kidney injury, severe electrolyte abnormality, symptomatic hypotension or hypertensive emergency)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of incomplete colonoscopies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: PTSD severity (PCL-5)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportions of participants regressing back to normal glucose level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of grade II-IV acute Graft Versus Host Disease (GVHD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Compressions within the depth target
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Low back pain occurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes